1.
Glasmacher A, Goldschmidt H, Mezger J, Haferlach T, Schmidt-Wolf I, Gieseler F, Phase II trial. Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial. Haematologica [Internet]. 2004Mar.1 [cited 2026Nov.7];89(3):371-3. Available from: https://haematologica.org/article/view/3017